Bioventus Completes CartiHeal Acquisition

Bioventus has completed its acquisition of CartiHeal.

CartiHeal is an alternative for the approximately 650,000 U.S. patients who receive microfracture or debridement annually, and can potentially delay the need for a total knee replacement in patients with joint surface lesions. The acquisition of CartiHeal is aligned with Bioventus’ sports...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us